Zare, K., Salehi, Z., Morovat, A. R., Aghajani, A., Mohammadi Pour, P., Ghanbariasad, A., & Naghizadeh, M. M. (2026). In silico analysis suggests ELL2 as a survival-associated cross-tissue biomarker in gastric cancer. Cancer Biomarkers, 43, 1. https://doi.org/10.1177/18758592261463305
Chicago Style (17th ed.) CitationZare, Kiarash, Zahra Salehi, Ali Reza Morovat, Ali Aghajani, Pardis Mohammadi Pour, Ali Ghanbariasad, and Mohammad Mehdi Naghizadeh. "In Silico Analysis Suggests ELL2 as a Survival-associated Cross-tissue Biomarker in Gastric Cancer." Cancer Biomarkers 43 (2026): 1. https://doi.org/10.1177/18758592261463305.
MLA (9th ed.) CitationZare, Kiarash, et al. "In Silico Analysis Suggests ELL2 as a Survival-associated Cross-tissue Biomarker in Gastric Cancer." Cancer Biomarkers, vol. 43, 2026, p. 1, https://doi.org/10.1177/18758592261463305.